Aceso Life Science Group Limited (0474) Stock Statistics & Valuation Metrics

Aceso Life Science Group Limited has a market cap or net worth of HKD 1.24B. The enterprise value is HKD 1.89B.

Market Cap

HKD 1.24B

Enterprise Value

HKD 1.89B

Aceso Life Science Group Limited has 8,858,127,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

8,858,127,000

Owned by Insiders

―

Owned by Institutions

0.02%

Aceso Life Science Group Limited’s return on equity (ROE) is 0.74 and return on invested capital (ROIC) is 2.23%.

Return on Equity (ROE)

0.74

Return on Assets (ROA)

0.19

Return on Invested Capital (ROIC)

2.23%

Return on Capital Employed (ROCE)

0.02

Revenue Per Employee

2.29M

Profits Per Employee

12.07M

Employee Count

28

Asset Turnover

0.04

Inventory Turnover

0.00

The current PE Ratio of Aceso Life Science Group Limited is 2.96. Aceso Life Science Group Limited’s PEG ratio is 0.01.

PE Ratio

2.96

PS Ratio

19.38

PB Ratio

2.72

Price to FCF

-15.70

Price to Operating Cash Flow

-15.75

PEG Ratio

0.01

In the last 12 months, Aceso Life Science Group Limited had revenue of 64.00M and earned 338.00M in profits. Earnings per share was -0.06.

Revenue

64.00M

Gross Profit

54.00M

Operating Income

40.00M

Pretax Income

-421.00M

Net Income

338.00M

EBITDA

-297.00M

Earnings Per Share (EPS)

-0.06

In the last 12 months, operating cash flow was -79.00M and capital expenditures 0, giving a free cash flow of -79.00M billion.

Operating Cash Flow

-79.00M

Free Cash Flow

-79.00M

Free Cash Flow per Share

-0.01

Aceso Life Science Group Limited pays an annual dividend of HKD 0.06, resulting in a dividend yield of ―

Dividend Per Share

HKD 0.06

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-6.37%

Earnings Yield

27.16%

Beta

0.32

52-Week Price Change

25.00%

50-Day Moving Average

0.14

200-Day Moving Average

0.12

Relative Strength Index (RSI)

44.33

Average Volume (3m)

3.37M

Aceso Life Science Group Limited upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).

Last Earnings Date

Jun 26, 2026

Next Earnings Date

Dec 01, 2026

Ex-Dividend Date

Aug 14, 2009

Aceso Life Science Group Limited as a current ratio of 5.52, with Debt / Equity ratio of 259.74%

Current Ratio

5.52

Quick Ratio

5.52

Debt to Market Cap

1.70

Net Debt to EBITDA

-3.51

Interest Coverage Ratio

0.35

In the past 12 months, Aceso Life Science Group Limited has paid 8.00M in taxes.

Income Tax

8.00M

Effective Tax Rate

-0.02

Aceso Life Science Group Limited EV to EBITDA ratio is -2.94, with an EV/FCF ratio of -28.89.

EV to Sales

35.66

EV to EBITDA

-2.94

EV to Free Cash Flow

-28.89

EV to Operating Cash Flow

-28.89

Aceso Life Science Group Limited has HKD 345.00M in cash and marketable securities with HKD 1.19B in debt, giving a net cash position of -HKD 842.00M billion.

Cash & Marketable Securities

HKD 345.00M

Total Debt

HKD 1.19B

Net Cash

-HKD 842.00M

Net Cash Per Share

-HKD 0.10

Tangible Book Value Per Share

HKD 0.05

Gross margin is 100.00%, with operating margin of 62.50%, and net profit margin of 528.13%.

Gross Margin

100.00%

Operating Margin

62.50%

Pretax Margin

-657.81%

Net Profit Margin

528.13%

EBITDA Margin

-1212.50%

EBIT Margin

-1212.50%

The average price target for Aceso Life Science Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-57.48%

EPS Growth Forecast

―

Smart Score

10

AI Score

51